<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of female pattern hair loss</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of female pattern hair loss</h1>
<div class="graphic"><div class="figure"><div class="ttl">Management of female pattern hair loss</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Assess all patients for signs of hyperandrogenism (eg, hirsutism, irregular menses, moderate to severe acne, treatment-refractory adult acne, acanthosis nigricans, or galactorrhea), and pursue hyperandrogenism testing in those with suggestive clinical features. Treatment of associated hyperandrogenism improves outcomes in the subset of patients with hyperandrogenism-associated FPHL and may be sufficient for some patients. Refer to additional UpToDate content on the diagnosis of FPHL for details.<br/>
Treatment aims to prevent progression of hair loss and improve hair density to a point that is cosmetically satisfactory for the patient (ie, good response). Initiating treatment prior to extensive hair loss is preferred because responses to treatment are variable and can be incomplete.<br/>
Patients may also benefit from adjunctive cosmetic measures that provide the appearance of increased hair coverage on the scalp (eg, hair styling techniques, hair dye, hair fibers, scalp micropigmentation, thickening shampoos, and wigs or other hair prostheses).</div><div class="graphic_footnotes">LLLT: low-level laser therapy;
FPHL: female pattern hair loss.<br/>
* We treat most patients with both topical minoxidil and an oral antiandrogen. Treatment with topical minoxidil alone is an alternative initial approach for patients who cannot tolerate or prefer to avoid oral antiandrogenic therapy. Spironolactone is our preferred initial oral antiandrogen based upon data that suggest benefit and the extensive experience with this drug for other indications in females.<br/>
¶ Patient preferences about the mode of administration and treatment risks influence selection among these treatments. Refer to additional UpToDate content on the failure of initial therapy for FPHL for details. Some clinicians also use combination oral antiandrogenic therapy (eg, spironolactone and finasteride) when patients fail to respond to a single antiandrogen. However, data to confirm superior efficacy of combination therapy are lacking. We treat most patients with a single oral antiandrogen and reserve combination therapy for occasional, treatment-refractory cases.</div><div id="graphicVersion">Graphic 134317 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
